Approach of an Academic Ophthalmology Department to Recovery During the Coronavirus Pandemic.

COVID-19 coronavirus ophthalmology pandemic resurgence

Journal

Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512

Informations de publication

Date de publication:
2022
Historique:
received: 02 10 2021
accepted: 18 01 2022
entrez: 18 3 2022
pubmed: 19 3 2022
medline: 19 3 2022
Statut: epublish

Résumé

A methodology for safe recovery of an ophthalmology department during a pandemic does not currently exist. This study describes successful recovery strategies for an urban, multi-specialty ophthalmology department serving a high-risk patient population. The study took place at a large multi-specialty tertiary care academic ophthalmology department in a metropolitan city during a seven-month period (March-October 2020). Five recovery ad hoc committees were charged with formulating metrics and initiatives to manage clinical volumes while maintaining safe practices, providing patient access, and minimizing financial damage. A six-tier system was created to resume non-urgent appointments in May 2020. Educational and research activities were maintained through the development of virtual curricula and research platforms. The number of clinical and surgical visits per month in 2020 compared to 2019 and the time to reach ≥95% of pre-COVID patient volumes were monitored. In October 2020, ≥95% of pre-COVID volumes were attained (11,975 vs 12,337 patient visits in October 2019; 266 vs 272 surgical cases in October 2019). Despite significant financial losses, the department surpassed December 2019 collections in December 2020. No faculty, staff, or trainees received furloughs or pay cuts. There was no COVID-19 transmission between faculty, staff, and patients. With strategic implementation of recovery strategies following CDC safety measures, it was possible to safely deliver care to patients with urgent and non-urgent eye conditions. Patient volumes were fully recovered in an ambulatory urban healthcare setting within a high-risk COVID-19 population within seven months while educational and research missions were successfully sustained.

Identifiants

pubmed: 35300030
doi: 10.2147/OPTH.S342300
pii: 342300
pmc: PMC8921828
doi:

Types de publication

Journal Article

Langues

eng

Pagination

695-704

Informations de copyright

© 2022 Brodin et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Telemed Telecare. 2020 Aug 16;:1357633X20949796
pubmed: 32799736
Indian J Ophthalmol. 2020 May;68(5):725-730
pubmed: 32317434
J Diabetes Res. 2020 Oct 14;2020:9036847
pubmed: 33123599
Clin Ophthalmol. 2020 Dec 01;14:4155-4163
pubmed: 33293788
Curr Opin Ophthalmol. 2021 Mar 1;32(2):75-82
pubmed: 33315725
Eur J Ophthalmol. 2021 Sep;31(5):2259-2267
pubmed: 32962415
BJPsych Open. 2020 Dec 29;7(1):e24
pubmed: 33371927
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Clin Med. 2020 Jul 30;9(8):
pubmed: 32751615
J Clin Med. 2020 Apr 28;9(5):
pubmed: 32353982
J Cataract Refract Surg. 2021 Mar 1;47(3):345-351
pubmed: 32925656
Eye (Lond). 2021 Sep 28;:
pubmed: 34584232
Risk Manag Healthc Policy. 2021 Apr 19;14:1629-1636
pubmed: 33907480
Am J Infect Control. 2021 May;49(5):536-541
pubmed: 32980436
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
J Clin Med. 2020 May 09;9(5):
pubmed: 32397530
Clin Ophthalmol. 2015 Mar 18;9:513-6
pubmed: 25834388
Am J Ophthalmol. 2021 Mar;223:108-118
pubmed: 32976847
J Am Coll Surg. 2020 Aug;231(2):281-288
pubmed: 32278725
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1427-1436
pubmed: 32314034
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Br J Ophthalmol. 2015 Jun;99(6):823-31
pubmed: 25563767
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1207-1208
pubmed: 32412403
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2621-2628
pubmed: 33009973

Auteurs

Alexandra C Brodin (AC)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Madhura A Tamhankar (MA)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Gideon Whitehead (G)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

David MacKay (D)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Benjamin J Kim (BJ)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Joan M O'Brien (JM)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Classifications MeSH